In human papillomavirus (HPV)-based screening, a repeat HPV test is often recommended for HPV-positive women with normal cytology (HPV-pos/cyt-neg), but its absolute risk of cervical precancer (CIN3+) ...

C. H. LAI, A. CHAO, C. J. CHANG, C. C. HUANG, L. C. WANG, S. HSUEH, C. T. LIN, T. I. WU, M. S. JAO and H. H. CHOU The prevalence and genotype distribution of human ...

April 22, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has issued a committee opinion on routine pelvic examination and cervical cytology screening that will be published in ...

Knowledge of the prevalence of type-specific human papillomavirus (HPV) infections is necessary to predict the expected, and to monitor the actual, impact of HPV immunisation and to design effective ...

Cervical cancer has historically been a significant public health issue worldwide, causing substantial morbidity and mortality among women. Over recent decades, advances in screening, vaccination, and ...

HHS’s Health Resources and Services Administration released updated guidance for cervical cancer screening, which includes a ...

Clearance of Type-Specific, Low-Risk, and High-Risk Cervical Human Papillomavirus Infections in HIV-Negative and HIV-Positive Women This was a cross-sectional comparative study of 200 consenting ...

Please provide your email address to receive an email when new articles are posted on . HPV-based vs. cytology-based screening was tied to lower risks for invasive cervical cancer. Adverse events were ...

Patients at average risk of cervical cancer can self-collect samples at home for HPV analysis, per the American Cancer Society (ACS). Updated ACS guidelines allow discontinuing screening after ...

Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new ...

Gls-010, a novel anti-PD-1 mAb in Chinese patients with recurrent or metastatic cervical cancer: Results from a multicenter, open-label and single-arm phase II trial. This is an ASCO Meeting Abstract ...

Enda McGarrity, Director at PA Duffy & Co Solicitors, with, from left, Leona Patterson, Heather Thompson and Tracey Bell from the Ladies with Letters campaign. A campaign group have said they feel "no ...